Alternatives to Spade Therapeutics

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.